Gastric cancer: evidence boosts Helicobacter pylori eradication

Hidekazu Suzuki; Juntaro Matsuzaki

doi:10.1038/s41575-018-0023-8

Gastric cancer: evidence boosts Helicobacter pylori eradication

Hidekazu Suzuki, Juntaro Matsuzaki

Medical Education Center

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Nature Reviews Gastroenterology and Hepatology
DOIs	https://doi.org/10.1038/s41575-018-0023-8
Publication status	Accepted/In press - 2018 Apr 30

ASJC Scopus subject areas

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41575-018-0023-8

Cite this

@article{b617c46b3ede4cdea8344b192c5c8a4c,

title = "Gastric cancer: evidence boosts Helicobacter pylori eradication",

abstract = "The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.",

author = "Hidekazu Suzuki and Juntaro Matsuzaki",

year = "2018",

month = apr,

day = "30",

doi = "10.1038/s41575-018-0023-8",

language = "English",

pages = "1--2",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Gastric cancer

T2 - evidence boosts Helicobacter pylori eradication

AU - Suzuki, Hidekazu

AU - Matsuzaki, Juntaro

PY - 2018/4/30

Y1 - 2018/4/30

N2 - The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

AB - The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

UR - http://www.scopus.com/inward/record.url?scp=85046106631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046106631&partnerID=8YFLogxK

U2 - 10.1038/s41575-018-0023-8

DO - 10.1038/s41575-018-0023-8

M3 - Article

C2 - 29713024

AN - SCOPUS:85046106631

SP - 1

EP - 2

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

ER -

Gastric cancer: evidence boosts Helicobacter pylori eradication

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this